🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01248780
Treatments Being Tested
A Canadian study to evaluate early use of adalimumab after methotrexate fai...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01162421
Treatments Being Tested
This is a randomized controlled trial to compare three currently available ...
Status
Completed
Location
University of California San Francisco
Start Date
2014-07-25
Trial ID
NCT02152696
Treatments Being Tested
The purpose of this study is to determine whether methotrexate is a effecti...
Status
Terminated
Location
Hôpital Avicenne - Service de Médecine Interne
Start Date
2009-09
Trial ID
NCT00918554
Treatments Being Tested
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929...
Status
Active Not Recruiting
Location
Cancer Clinic
Start Date
2019-05-09
Trial ID
NCT03769506
Treatments Being Tested
This phase II/III trial tests the safety, side effects, and best dose of th...
Status
Suspended
Location
Children's Hospital of Alabama
Start Date
2023-03-03
Trial ID
NCT05691478
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
This is a multicenter, Phase II, randomized, double-blind, placebo-controll...
Status
Completed
Location
Pinnacle Research Group; Llc, Central
Start Date
2016-09-09
Trial ID
NCT02833350
Treatments Being Tested
Pharmacokinetics (PK) study...
Status
Completed
Location
Altoona Center for Clinical Research
Start Date
2011-01
Trial ID
NCT01737944
Treatments Being Tested
Primary Objective: To evaluate the efficacy of sarilumab at Week 16 in par...
Status
Completed
Location
Investigational Site Number 840008
Start Date
2013-10
Trial ID
NCT01900431
Treatments Being Tested